Guest guest Posted December 22, 2007 Report Share Posted December 22, 2007 can say I totally agree with this is all aspects BUT tiz pretty good all the same........... http://brodyhooked.blogspot.com:80/2007/12/new-cholesterol-controversies-regaining.html New Cholesterol Controversies: Regaining Perspective Cholesterol drugs are making some of the big news this week. First, we read that Pfizer is facing a whistle-blower lawsuit regarding purported off-label marketing of Lipitor--trying to persuade physicians to prescribe the drug for lower-risk categories of patients than officially approved (for a wrap up see the WSJ Health blog, http://blogs.wsj.com/health/2007/12/20/a-jug-of-wine-a-loaf-of-bread-and-lipitor/). Then comes the news that Merck and Schering-Plough, already under fire for the delays in releasing the ENHANCE study of Zetia, have been hit by reports that they also have failed to publish other research showing liver damage in patients taking that drug. The risk is admittedly low, but apparently more than had earlier been admitted (see Berenson in today's New York Times).It can be a bit challenging to keep all this stuff in perspective--what does it really mean for the treatment of high cholesterol? Here's my view. http://www.grisoft.com Anti-Virus Scanned this message Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.